Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Parallel, Comparison, Double-Blind Efficacy & Safety Study of APROVEL Versus Placebo in Chinese Patients With Hypertensive Type II Diabetic Patients With Microalbuminuria

NCT00561964 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00561964
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00561964 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Parallel, Comparison, Double-Blind Efficacy & Safety Study of APROVEL Versus Placebo in Chinese Patients With Hypertensive Type II Diabetic Patients With Microalbuminuria
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2004
Completion date
July 31, 2005
Enrollment
241 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension